New Hampshire Trust’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$224K Buy
+1,530
New +$277K 0.04% 168
2026
Q1
Sell
-1,705
Closed -$332K 167
2025
Q4
$332K Buy
1,705
+446
+35% +$106K 0.06% 138
2025
Q3
$354K Buy
1,259
+31
+3% +$7.89K 0.07% 145
2025
Q2
$268K Buy
+1,228
New +$198K 0.06% 166
2025
Q1
Sell
-1,313
Closed -$219K 178
2024
Q4
$219K Sell
1,313
-137
-9% -$24.3K 0.05% 171
2024
Q3
$247K Buy
+1,450
New +$210K 0.05% 167
2023
Q2
Sell
-1,455
Closed -$135K 286
2023
Q1
$135K Sell
1,455
-159
-10% -$13.9K 0.04% 197
2022
Q4
$132K Buy
+1,614
New +$123K 0.03% 195

Other funds holding ORCL

New Hampshire Trust's ORCL Position: Q2 2026 in Review

New Hampshire Trust opened a new position in Oracle (ORCL) in Q2 2026: 1,530 shares worth $224K. The stake represents 0.04% of the portfolio and ranks #168 among its holdings. This is a return to the name: New Hampshire Trust previously reported a position in ORCL as recently as Q4 2025.

New Hampshire Trust first reported a position in ORCL in Q4 2022 and has held it in 8 quarters since. The position peaked at $354K in Q3 2025. 1,593 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • New Hampshire Trust held 1,530 shares of Oracle worth $224K as of Q2 2026.
  • Oracle was a new New Hampshire Trust position in Q2 2026.
  • Oracle made up 0.04% of New Hampshire Trust's portfolio in Q2 2026, its #168 holding.
  • New Hampshire Trust first reported a position in Oracle in Q4 2022 and has held it in 8 quarters since.
  • New Hampshire Trust's Oracle position peaked at $354K in Q3 2025.
  • 1,593 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on New Hampshire Trust's 13F filing for Q2 2026, filed 27 Jul 2026.